| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
40,609 |
37,078 |
$1.57M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
35,772 |
32,698 |
$1.23M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
36,075 |
32,958 |
$1.20M |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
27,613 |
25,214 |
$944K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
3,580 |
3,277 |
$183K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,644 |
3,476 |
$182K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,878 |
2,171 |
$103K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,967 |
2,619 |
$75K |
| 87481 |
|
2,016 |
1,730 |
$65K |
| 87563 |
|
1,960 |
1,698 |
$50K |
| 87511 |
|
1,082 |
999 |
$35K |
| 87070 |
|
3,348 |
3,070 |
$27K |
| 87625 |
|
681 |
628 |
$22K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
369 |
311 |
$16K |
| 87536 |
|
59 |
58 |
$5K |
| 87071 |
|
418 |
414 |
$4K |
| 88142 |
|
108 |
101 |
$3K |
| 87081 |
|
413 |
266 |
$3K |
| 87186 |
|
348 |
279 |
$3K |
| 86360 |
|
44 |
44 |
$2K |
| 86769 |
|
41 |
40 |
$1K |
| 86703 |
|
49 |
49 |
$571.25 |
| 86328 |
|
22 |
22 |
$519.28 |
| 86592 |
|
123 |
120 |
$486.14 |
| 87653 |
|
15 |
15 |
$473.34 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
59 |
58 |
$446.64 |
| 36415 |
Collection of venous blood by venipuncture |
49 |
49 |
$432.10 |
| 86361 |
|
15 |
14 |
$400.36 |
| 86780 |
|
14 |
13 |
$171.26 |
| 86593 |
|
14 |
14 |
$61.06 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
12 |
12 |
$0.00 |